In addition, there may be significant inter-individual variation in the accepted thresholds for stroke prevention at the cost of additional bleeding events.
← all excerpts
Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit.
1
—
—